| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |